Margaret Piper

5.0k citations

52 papers · 2.9k indexed · 2 hit papers · h-index 20

Hematology top 1%
- Erythropoietin and Anemia Treatment 14
- Iron Metabolism and Disorders 5
Biochemistry top 2%
Oncology top 5%
Internal Medicine top 5%
Cancer Research top 5%
- Cancer Genomics and Diagnostics 4
Economics and Econometrics
- Health Systems, Economic Evaluations, Quality of Life 6
Genetics
- BRCA gene mutations in cancer 5
- Hemoglobinopathies and Related Disorders 4
Statistics and Probability
- Statistical Methods in Clinical Trials 4
Immunology
- T-cell and B-cell Immunology 4

Co-authors: Evelyn P Whitlock Elizabeth O’Connor Elizabeth M. Webber James E. Haddow Jerome Seidenfeld Leslie A Perdue Jennifer S Lin Ned Calonge
Cited by: Hematology Biochemistry Oncology
Partner nations: United States United Kingdom Germany

In The Last Decade

Margaret Piper

51 papers receiving 2.8k citations

Hit Papers

align trajectories log scale

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

2016 Screening for Colorectal Cancer
2009 The Evaluation of Genomic Applications in Practice and Prevention (EGAPP) initiative: methods of the EGAPP Working Group

Peers

Countries citing papers authored by Margaret Piper

Since Specialization

Citations

This map shows the geographic impact of Margaret Piper's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Margaret Piper with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Margaret Piper more than expected).

Fields of papers citing papers by Margaret Piper

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Margaret Piper. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Margaret Piper. The network helps show where Margaret Piper may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Margaret Piper, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Margaret Piper Line = papers co-authored together Margaret Piper links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Spaces of well‐being and regional settlement: International migrants and the rural idyll Natascha Klocker,Paul Hodge,Olivia Dun,Eliza Crosbie,Rae Dufty‐Jones,Celia McMichael,Karen Block,Margaret Piper,Emmanuel Musoni,Lynda L. Ford,Carly N. Jordan,D. C. Radford	2021	17
2	Updated Evidence Report and Systematic Review for the US Preventive Services Task Force Jennifer S Lin,Margaret Piper,Leslie A Perdue,Carolyn M. Rutter,Elizabeth M. Webber,Elizabeth O’Connor,Yang Liu,Evelyn P Whitlock	2016	2
3	Generating and evaluating evidence of the clinical utility of molecular diagnostic tests in oncology Patricia A. Deverka,Donna A. Messner,Robert McCormack,Gary H. Lyman,Margaret Piper,Linda Bradley,David Parkinson,David M. Nelson,Mary Lou Smith,Louis F. Jacques,Tania Dutta,Sean Tunis	2015	17
4	Screening for High Blood Pressure in Adults: A Systematic Evidence Review for the U.S. Preventive Services Task Force Margaret Piper,Corinne V. Evans,Brittany U Burda,Karen L. Margolis,Elizabeth O’Connor,Ning Smith,Elizabeth M. Webber,Leslie A Perdue,Keshia D Bigler,Evelyn P Whitlock	2014	52
5	Improving the efficiency and relevance of evidence-based recommendations in the era of whole-genome sequencing: an EGAPP methods update David L. Veenstra,Margaret Piper,James E. Haddow,Stephen G. Pauker,Roger D. Klein,Carolyn Sue Richards,Sean Tunis,Benjamin Djulbegović,Michael Marrone,Jennifer S Lin,Alfred O. Berg,Ned Calonge	2012	40
6	A Health Services Research Agenda for Cellular, Molecular and Genomic Technologies in Cancer Care Louise Wideroff,Kathryn A. Phillips,Gurvaneet Randhawa,Anita Ambs,Katrina Armstrong,Charles L. Bennett,Martin L. Brown,Molla S. Donaldson,Michele Follen,Sue J. Goldie,Robert A. Hiatt,Muin J. Khoury,Graham Lewis,Howard L. McLeod,Margaret Piper,Isaac J. Powell,Deborah Schrag,Kevin A. Schulman,Joan Scott	2009	13
7	The Evaluation of Genomic Applications in Practice and Prevention (EGAPP) initiative: methods of the EGAPP Working Groupbreakdown → Steven M. Teutsch,Linda Bradley,Glenn E. Palomaki,James E. Haddow,Margaret Piper,Ned Calonge,W. David Dotson,Michael P. Douglas,Alfred O. Berg	2009	484
8	A Rapid-ACCE review of CYP2C9 and VKORC1 alleles testing to inform warfarin dosing in adults at elevated risk for thrombotic events to avoid serious bleeding Monica R. McClain,Glenn E. Palomaki,Margaret Piper,James E. Haddow	2008	60
9	Recombinant Human Erythropoietins and Cancer Patients: Updated Meta-Analysis of 57 Studies Including 9353 Patients Julia Bohlius,Jayne S. Wilson,Jerome Seidenfeld,Margaret Piper,Guido Schwarzer,Josie Sandercock,Sven Trelle,Olaf Weingart,Susan Bayliss,Benjamin Djulbegović,Charles L. Bennett,Simon Langensiepen,Chris Hyde,Andreas Engert	2006	392
10	Recombinant Human Erythropoietin and Overall Survival in Cancer Patients: Results of a Comprehensive Meta-analysis Julia Bohlius,Sina Langensiepen,Guido Schwarzer,Jerome Seidenfeld,Margaret Piper,Charles L. Bennett,Andreas Engert	2005	165
11	Risk Factors for an Untoward Medication Event Among Elders in Community‐Based Nursing Caseloads in Australia Maree Johnson,Rhonda Griffiths,Margaret Piper,Rachel Langdon	2005	34
12	A nursing intervention for the quality use of medicines by elderly community clients Rhonda Griffiths,Maree Johnson,Margaret Piper,Rachel Langdon	2004	44
13	Erythropoietin: A Paradigm for the Development of Practice Guidelines J. Douglas Rizzo,Jerome Seidenfeld,Margaret Piper,Naomi Aronson,Alan Lichtin,Timothy J. Littlewood	2001	30
14	Race-specific results of Papanicolaou testing and the rate of cervical neoplasia in the National Breast and Cervical Cancer Early Detection Program, 1991–1998 (United States) Vicki B. Benard,Nancy C. Lee,Margaret Piper,Lisa C. Richardson	2001	67
15	Epoetin Treatment of Anemia Associated With Cancer Therapy: a Systematic Review and Meta-analysis of Controlled Clinical Trials Justine Seidenfeld,Margaret Piper,Carson Flamm,Victor Hasselblad,Jamés O. Armitage,Charles L. Bennett,Michael S. Gordon,Alan Lichtin,James L. Wade,Steven H. Woolf,Naomi Aronson	2001	169
16	The Role of State Public Health Agencies in Genetics and Disease Prevention: Results of a National Survey Margaret Piper	2001	16
17	Australia's Refugee Policy Margaret Piper	2000	2
18	Association of human papillomavirus with HIV and CD4 cell count in women with high or low numbers of sex partners Margaret Piper,Sibailly T Severin,Stefan Z. Wiktor,Elizabeth R. Unger,Peter D. Ghys,Donna L. Miller,Ira Horowitz,Alan E. Greenberg,William C. Reeves,Suzanne D. Vernon	1999	18
19	HIV and human papillomavirus as independent risk factors for cervical neoplasia in women with high or low numbers of sex partners Suzanne D. Vernon,Elizabeth R. Unger,Margaret Piper,Sibailly T Severin,Stefan Z. Wiktor,Peter D. Ghys,Donna L. Miller,Ira Horowitz,Alan E. Greenberg,William C. Reeves	1999	19
20	Hypocomplementemic Proliferative Glomerulonephritis with C3 Nephritic-Factor-Like Activity in Multiple Myeloma Edmund Bourke,Wallace G. Campbell,Margaret Piper,Irene J. Check	1989	7

About Margaret Piper

Margaret Piper is a scholar working on Hematology, Family Practice and Geriatrics and Gerontology, having authored 52 papers that have together received 2.9k indexed citations. Recurring topics across this work include Erythropoietin and Anemia Treatment (14 papers), Health Systems, Economic Evaluations, Quality of Life (6 papers), BRCA gene mutations in cancer (5 papers), Iron Metabolism and Disorders (5 papers), Cancer Genomics and Diagnostics (4 papers), Statistical Methods in Clinical Trials (4 papers), Hemoglobinopathies and Related Disorders (4 papers) and T-cell and B-cell Immunology (4 papers). The work is most often cited by research in Hematology (798 citations), Biochemistry (220 citations) and Oncology (969 citations). Margaret Piper has collaborated with scholars based in United States, United Kingdom and Germany. Frequent co-authors include Evelyn P Whitlock, Elizabeth O’Connor, Elizabeth M. Webber, James E. Haddow, Jerome Seidenfeld, Leslie A Perdue, Jennifer S Lin, Ned Calonge, Glenn E. Palomaki and Charles L. Bennett.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact